Asia-Pacific Transfection Reagents And Equipment Market

Asia-Pacific Transfection Reagents And Equipment Market Size Worth $283.81
billion by 2021 | CAGR: 8.0%
The Asia-Pacific Transfection Reagents and Equipment market size approximately was
USD 193.16 million in 2016. It is expected to grow at a CAGR of 8 % to reach USD 283.81
million by 2021. It captures a market share of 27%.
The process involving the injection of genetic material, such as DNA and RNA, into the
mammal’s cells is called transfection. Transfection reagents are the compounds which
contain the genetic material while the equipment is used as a delivery system.
Various technological advancements which have happened in the transfection reagents and
equipment market in the past has to certain level addressed the needs and wants of
researchers and biotechnology & biopharmaceutical companies. Transfection instruments
which have higher efficiency are also the result of these advancements. Further, efficient
quantitative and qualitative transfection in a plethora of cells, including the hard-to-transfect
cells are also the result of the technological advancements.
View Full Report: http://marketdataforecast.com/market-reports/asia-pacifictransfection-reagents-and-equipment-market-3220/
Rise in demand for synthetic genes and increasing number of cases of cancer are primarily
driving the growth of this market. Further, technological advancements in transfections,
alliances worldwide betwixt the pioneering research institutes to trigger drug discovery,
augmented research and development spending along with research activities by
pharmaceutical and biotechnology companies are secondary factors contributing towards
the same end.
Selective effectiveness of transfection reagents is the key factor likely to hamper the growth
of this market. In addition, home brew reagents by researchers conjoined with hefty costs of
transfection reagents are secondary factors contributing towards the same end.
Request for Sample: http://marketdataforecast.com/market-reports/asia-pacifictransfection-reagents-and-equipment-market-3220/request-sample
The Asia-Pacific Transfection Reagents and Equipment market can be categorized into four
categories: by product, by gimmick, by application and by end user. On the basis of product,
Transfection Reagents and Equipment market is classified into Reagents and Instruments.
In 2016, the reagents category is projected to account for the biggest market share.
Although, the instruments market is probably grow at the highest CAGR during the
aforementioned forecast period. If we go by gimmick, Transfection Reagents and
Equipment market is segmented into Biochemical, Calcium Phosphate, Lipofection, DEAEdextran, Dendrimers, Physical, Electroporation, Nucleofection, Others and Viral. In 2016,
the biochemical category is projected to command the largest market share, whereas the
viral category is estimated to grow at the highest CAGR during the aforementioned forecast
period. Further, on the basis of application the market can be categorized into Biomedical
Research, Gene Expression Studies, Cancer Research, Transgenic Model, Protein
Production and Therapeutic Delivery. In 2016, the biomedical research category is likely to
command the largest market share. Last but not the least, on the basis of end user the
market is segmented into Academic & Research Institutes and Pharmaceutical &
Biotechnology Companies. In 2016, the academic & research institutes category is likely to
command the largest market share. Although, the pharmaceutical & biotechnologies
category is estimated to grow at the highest CAGR during the aforementioned forecast
period.
Inquire Before Buying: http://marketdataforecast.com/market-reports/asiapacific-transfection-reagents-and-equipment-market-3220/inquire
By geography, the Asia-Pacific Transfection Reagents and Equipment market has been
categorized into China, India, Japan, South Korea, and Australia. It has the highest CAGR.
It captures similar market share as compared to Europe.
Major companies in the Transfection Reagents and Equipment market are Thermo Fisher
Scientific Inc. (U.S.), Promega Corporation (U.S.), Hoffmann-La Roche Ltd. (Switzerland),
and QIAGEN N.V. (Netherlands). These companies hold a leading position in the
transfection reagent and equipment market because of their well-established presence in
the fields of genomics, spanning fifty countries, heavy R&D investments, and strong sales
as well as distribution force. Other players in the market include Polyplus-transfection SA
(France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich
Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte Inc. (U.S.).
About Us:
Market Data Forecast is a firm working in the area of market research and business
intelligence. With rich experience in research across various business domains, we cater to
the needs of both individual and corporate clients. Our analyst team comprises expert
professionals in market research, who with their collective knowledge and sksillset
dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/pressreleases

Asia-Pacific Transfection Reagents and Equipment market size approximately was USD 193.16 million in 2016. It is expected to grow at a CAGR of 8 % to reach USD 283.81 million by 2021.

Download Report